Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00773
|
|||||
| Drug Name |
TZP-101
|
|||||
| Synonyms |
(3R,6S,9R,12R)-6-cyclopropyl-12-[(4-fluorophenyl)methyl]-3,8,9-trimethyl-2-oxa-5,8,11,14-tetrazabicyclo[16.4.0]docosa-1(22),18,20-triene-7,10,13-trione; 842131-33-3; BDBM50359256; CHEMBL1923502; CHEMBL1963249; D-Phenylalanine, (2S)-N-((2R)-2-(2-(3-aminopropyl)phenoxy)propyl)-2- cyclopropylglycyl-N-methyl-D-alanyl-4-fluoro-, (3-1)-lactam; D09981; DB12128; DTXSID00233139; GTPL3535; LGI67MCW2S; SCHEMBL804500; TZP 101; TZP-101; TZP101; UNII-LGI67MCW2S; Ulimorelin; Ulimorelin (USAN/INN); Ulimorelin [USAN:INN]
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C30H39FN4O4
|
|||||
| Canonical SMILES |
CC1CNC(C(=O)N(C(C(=O)NC(C(=O)NCCCC2=CC=CC=C2O1)CC3=CC=C(C=C3)F)C)C)C4CC4
|
|||||
| InChI |
InChI=1S/C30H39FN4O4/c1-19-18-33-27(23-12-13-23)30(38)35(3)20(2)28(36)34-25(17-21-10-14-24(31)15-11-21)29(37)32-16-6-8-22-7-4-5-9-26(22)39-19/h4-5,7,9-11,14-15,19-20,23,25,27,33H,6,8,12-13,16-18H2,1-3H3,(H,32,37)(H,34,36)/t19-,20-,25-,27+/m1/s1
|
|||||
| InChIKey |
WGYPAJVJMXQXTR-ABNZCKJZSA-N
|
|||||
| Pharmaceutical Properties | Molecular Weight | 538.7 | Topological Polar Surface Area | 99.8 | ||
| Heavy Atom Count | 39 | Rotatable Bond Count | 3 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
3.8
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.